Elisabeth Sthengel

Chief Tech/Sci/R&D Officer at INVENT MEDIC SWEDEN AB

Health Technology

Profile

Elisabeth Sthengel is currently working as Manager-Design, Development & Clinical at Invent Medic Sweden AB since 2017.
Prior to this, she worked as Laboratory Manager at NOLabs AB.

Elisabeth Sthengel active positions

Companies	Position	Start
INVENT MEDIC SWEDEN AB	Chief Tech/Sci/R&D Officer	2017-05-31

All active positions of Elisabeth Sthengel

Former positions of Elisabeth Sthengel

Companies	Position	End
NOLabs AB NOLabs AB Medical SpecialtiesHealth Technology NOLabs AB is a holding company that explores and develops proprietary therapies for diabetic patients where current treatment options are insufficient or complicated. It is a medical device company that focuses on its core technology, as well as the development of therapeutic applications for diabetic pain relief. Its product contains NitroSense Nitric Oxide (NO) delivery system and is a multilayer patch that is designed to release NO in a controlled manner. The firm core concept of NitroSense Technology is combining a substance and a delivery system to create h products for local delivery of NO. The company was founded in 2004 and is headquartered in Helsingborg, Sweden.	Corporate Officer/Principal	-

See the detail of Elisabeth Sthengel's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Elisabeth Sthengel's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
INVENT MEDIC SWEDEN AB	Health Technology

Private companies	1
NOLabs AB NOLabs AB Medical SpecialtiesHealth Technology NOLabs AB is a holding company that explores and develops proprietary therapies for diabetic patients where current treatment options are insufficient or complicated. It is a medical device company that focuses on its core technology, as well as the development of therapeutic applications for diabetic pain relief. Its product contains NitroSense Nitric Oxide (NO) delivery system and is a multilayer patch that is designed to release NO in a controlled manner. The firm core concept of NitroSense Technology is combining a substance and a delivery system to create h products for local delivery of NO. The company was founded in 2004 and is headquartered in Helsingborg, Sweden.	Health Technology